895 studies found for:    Open Studies | "Carcinoma, Bronchogenic"
Show Display Options
Rank Status Study
1 Recruiting SAS in Patients With Bronchial Carcinoma
Conditions: Sleep Apnea Syndrome;   Bronchial Carcinoma
Intervention: Device: sleep apnea screening with ApneaLinkTM
2 Unknown  Efficacy and Safety Study of Gefitinib in Squamous NSCLC Patients Who Failed First-Line Chemotherapy
Condition: Squamous Cell Carcinoma of Bronchus
Intervention: Drug: Gefitinib
3 Unknown  Study to Determine the Efficacy of Bendamustin in Patients With Recurrent Small Cell Lung Cancer (SCLC)
Condition: Recurrent Small Cell Lung Cancer
Intervention: Drug: Bendamustin/Ribomustin
4 Recruiting Comparison of Different Types of Surgery in Treating Patients With Early-stage Non-small Cell Lung Cancer
Conditions: Stage IA Non-small Cell Lung Cancer;   Adenocarcinoma of the Lung;   Squamous Cell Lung Cancer
Intervention:
5 Recruiting Phase I Trial of Afatinib (BIBW 2992) and Dasatinib in Non-small Cell Lung Cancer (NSCLC)
Conditions: Lung Cancer;   Non-small Cell Lung Cancer (NSCLC)
Interventions: Drug: Dasatinib - 1A;   Drug: Afatinib - 1A;   Drug: Dasatinib - 1B;   Drug: Afatinib - 1B
6 Unknown  Biomarkers Predicting Response in Patients With Non-Small Cell Lung Cancer Previously Treated With Erlotinib Hydrochloride
Condition: Lung Cancer
Interventions: Other: enzyme-linked immunosorbent assay;   Other: laboratory biomarker analysis
7 Not yet recruiting Pemetrexed Disodium and Carboplatin or Cisplatin With or Without Erlotinib Hydrochloride in Treating Patient With Stage IV Non-Small Cell Lung Cancer Resistant to First-Line Therapy With Erlotinib Hydrochloride or Gefitinib
Conditions: Recurrent Non-small Cell Lung Cancer;   Stage IV Non-small Cell Lung Cancer
Interventions: Drug: pemetrexed disodium;   Drug: carboplatin;   Drug: cisplatin;   Drug: erlotinib hydrochloride;   Other: laboratory biomarker analysis
8 Unknown  Study of Efficacy of Induction Chemotherapy With Gemcitabine and Carboplatin for Operable Non-small-cell Lung Cancer Before Surgery
Condition: Lung Neoplasms
Interventions: Drug: gemcitabine, carboplatin;   Procedure: surgery
9 Recruiting Vaccine Therapy in Treating Patients With Persistent or Recurrent Cervical Cancer
Conditions: Cervical Adenocarcinoma;   Cervical Adenosquamous Carcinoma;   Cervical Small Cell Carcinoma;   Cervical Squamous Cell Carcinoma;   Recurrent Cervical Carcinoma;   Stage III Cervical Cancer;   Stage IVA Cervical Cancer;   Stage IVB Cervical Cancer
Interventions: Biological: Attenuated Live Listeria Encoding HPV 16 E7 Vaccine ADXS11-001;   Other: Laboratory Biomarker Analysis
10 Recruiting Intercalating and Maintenance Use of Iressa Versus Chemotherapy in Selected Advanced Non Small Cell Lung Cancer
Condition: Non-small Cell Lung Cancer
Intervention: Drug: gefitinib
11 Recruiting Radiotherapy Combined With Iressa for EGFR Mutation Positive Patients With Locally Advanced Non-small Cell Lung Cancer (NSCLC)
Condition: Non-small Cell Lung Cancer
Intervention: Other: Gefitinib
12 Unknown  Chemotherapy With or Without Radiosurgery for Asymptomatic Oligo Brain Metastasis
Condition: Nonsmall Cell Lung Cancer
Interventions: Radiation: Radiosurgery;   Radiation: Observation
13 Recruiting CAP7.1 for the Treatment of Advanced Stage, Therapy Refractory Lung and Biliary Tract Tumors
Condition: Advanced Endstage Solid Carcinomas in Adults
Intervention: Drug: CAP7.1
14 Recruiting Cisplatin and Nab-paclitaxel for (N2) Defined NSCLC
Condition: Stage IIIA Non-Small Cell Lung Cancer
Interventions: Drug: Neoadjuvant Cisplatin, nab-paclitaxel;   Drug: Adjuvant Cisplatin,nab-paclitaxel;   Drug: Adjuvant cisplatin+pemetrexed or cisplatin+gemcitabine
15 Recruiting A Phase I/IB Trial of MEK162 in Combination With Erlotinib in NSCLC Harboring KRAS or EGFR Mutation
Conditions: Lung Cancer;   Non-Small Cell Lung Cancer
Interventions: Drug: MEK162;   Drug: Erlotinib
16 Recruiting Ipilimumab Plus Targeted Inhibitor (Erlotinib or Crizotinib) for EGFR or ALK Mutated Stage IV Non-small Cell Lung Cancer: Phase Ib With Expansion Cohorts
Condition: Non-small Cell Lung Cancer
Interventions: Drug: Ipilimumab;   Drug: Erlotinib;   Drug: Crizotinib
17 Recruiting Trial Of Cisplatin And KML-001 in Platinum Responsive Malignancies
Conditions: Non-Small Cell Lung Cancer, Small Cell Lung Cancer;   Platinum Responsive Malignancies
Interventions: Drug: KML-001;   Drug: Cisplatin
18 Recruiting Study of Efficacy and Safety of Nivolumab in Combination With EGF816 and of Nivolumab in Combination With INC280 in Patients With Previously Treated Non-small Cell Lung Cancer
Condition: Non Small Cell Lung Cancer
Interventions: Drug: EGF816;   Drug: INC280;   Drug: Nivolumab
19 Recruiting Bevacizumab or Pemetrexed Disodium Alone or In Combination After Induction Therapy in Treating Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer
Condition: Lung Cancer
Interventions: Biological: bevacizumab;   Drug: pemetrexed disodium
20 Recruiting Circulating Tumor Cells in Non-Small Cell Lung Carcinoma
Condition: Primary Lung Cancer
Intervention:

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years